01 1ASCLERA
02 2BETAGAN
03 1BLEPHAMIDE
04 1CYTALUX
05 1DACOGEN
06 10DECITABINE
07 1IMITREX
08 1ISOSULFAN BLUE
09 1LEVOBUNOLOL HYDROCHLORIDE
10 1NEO-FRADIN
11 2PREDNISOLONE SODIUM PHOSPHATE
12 8RANITIDINE HYDROCHLORIDE
13 1SPRIX
14 1SUMATRIPTAN
15 1VARITHENA
16 1VITRASE
17 1ZANTAC
18 1ZEVALIN
PREDNISOLONE ACETATE; SULFACETAMIDE SODIUM
Drug : BLEPHAMIDE
Dosage Form : SUSPENSION; OPHTHALMIC
Application Number : 12813
Country : US
Patented : No
Drug : BETAGAN
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 19219
Country : US
Patented : No
Drug : BETAGAN
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Application Number : 19814
Country : US
Patented : No
Drug : ASCLERA
Dosage Form : SOLUTION; INTRAVENOUS
Application Number : 21201
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : DECITABINE
Dosage Form : INJECTABLE; INTRAVENOUS
Application Number : 203131
Country : US
Patented : No
Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.
Drug : PREDNISOLONE SODIUM PHOSPHATE
Dosage Form : SOLUTION; ORAL
Application Number : 91396
Country : US
Patented : No
LOOKING FOR A SUPPLIER?
Market Place
